HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Cheng-Yuan Hsia Selected Research

Fetal Proteins (Fetoprotein)

11/2021Easy albumin-bilirubin score as a new prognostic predictor in hepatocellular carcinoma.
1/2019Albumin-bilirubin (ALBI) grade-based nomogram to predict tumor recurrence in patients with hepatocellular carcinoma.
1/2019An Albumin-Bilirubin (ALBI) Grade-based Prognostic Model For Patients With Hepatocellular Carcinoma Within Milan Criteria.
1/2017Prognostic role of noninvasive liver reserve markers in patients with hepatocellular carcinoma undergoing transarterial chemoembolization.
3/2016Surgical Resection is Better than Transarterial Chemoembolization for Patients with Hepatocellular Carcinoma Beyond the Milan Criteria: A Prognostic Nomogram Study.
11/2015Active Treatments Prolong the Survival in Patients With Hepatocellular Carcinoma and Performance Status 3 or 4: A Propensity Score Analysis.
1/2015Using serum α-fetoprotein for prognostic prediction in patients with hepatocellular carcinoma: what is the most optimal cutoff?
9/2014Vascular invasion in hepatocellular carcinoma: prevalence, determinants and prognostic impact.
1/2014A new Child-Turcotte-Pugh class 0 for patients with hepatocellular carcinoma: determinants, prognostic impact and ability to improve the current staging systems.
1/2014Decrypting cryptogenic hepatocellular carcinoma: clinical manifestations, prognostic factors and long-term survival by propensity score model.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Cheng-Yuan Hsia Research Topics

Disease

35Neoplasms (Cancer)
01/2022 - 05/2003
32Hepatocellular Carcinoma (Hepatoma)
04/2022 - 05/2003
13Liver Neoplasms (Liver Cancer)
11/2021 - 09/2007
10End Stage Liver Disease
01/2022 - 09/2007
8Neoplasm Metastasis (Metastasis)
11/2021 - 09/2009
7Ascites
11/2021 - 03/2013
6Fibrosis (Cirrhosis)
11/2021 - 02/2013
4Hepatitis B
04/2022 - 06/2007
2Infections
04/2022 - 05/2009
2Chronic Hepatitis B
04/2022 - 05/2009
2Diabetes Mellitus
01/2018 - 09/2015
2Liver Diseases (Liver Disease)
04/2017 - 08/2016
1Disease Progression
01/2022
1Methylmalonic acidemia
01/2022
1Neonatal hemochromatosis
07/2021
1Rectal Neoplasms (Rectal Cancer)
01/2021
1Colonic Neoplasms (Colon Cancer)
01/2021
1Chronic Hepatitis C
01/2020
1Lymphatic Metastasis
03/2017
1Cholangiocarcinoma
03/2017
1Hepatitis C
03/2016
1Hepatic Encephalopathy
01/2014
1Brain Diseases (Brain Disorder)
01/2014
1Mitochondrial Diseases (Mitochondrial Disease)
10/2013
1Hypoxia (Hypoxemia)
10/2013
1Homocystinuria
11/2012
1Infarction (Infarctions)
11/2012
1Hypertension (High Blood Pressure)
11/2012
1Myopia
11/2012
1Lens Subluxation
11/2012
1Cholestasis
03/2012
1Wounds and Injuries (Trauma)
03/2012
1Chronic Idiopathic Jaundice (Dubin Johnson Syndrome)
02/2012
1Pathologic Constriction (Stenosis)
02/2012
1Stroke (Strokes)
02/2012
1Jaundice (Icterus)
01/2012
1Cholangitis
01/2012

Drug/Important Bio-Agent (IBA)

12Fetal Proteins (Fetoprotein)IBA
11/2021 - 02/2013
11BilirubinIBA
04/2022 - 02/2010
9AlbuminsIBA
04/2022 - 01/2014
8Cytidine Triphosphate (CTP)IBA
11/2021 - 09/2007
5alpha-Fetoproteins (alpha-Fetoprotein)IBA
01/2022 - 06/2007
5Proteins (Proteins, Gene)FDA Link
12/2021 - 02/2012
5Serum AlbuminIBA
03/2016 - 02/2010
5SodiumIBA
09/2014 - 09/2009
4CreatinineIBA
03/2016 - 02/2010
3Alkaline PhosphataseIBA
01/2017 - 01/2016
2Indocyanine Green (Cardio-Green)FDA LinkGeneric
01/2021 - 11/2012
2Alanine Transaminase (SGPT)IBA
01/2014 - 02/2010
1Androgen Receptors (Androgen Receptor)IBA
12/2021
1Steroid Receptors (Steroid Receptor)IBA
12/2021
1Biomarkers (Surrogate Marker)IBA
11/2021
1N 30IBA
01/2021
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2021
1Immunosuppressive Agents (Immunosuppressants)IBA
01/2020
1Antiviral Agents (Antivirals)IBA
01/2020
1InterferonsIBA
01/2020
1ClusterinIBA
12/2019
1Carcinoembryonic AntigenIBA
03/2017
1AntigensIBA
03/2017
1CarbohydratesIBA
03/2017
1lissamine rhodamine B (sulforhodamine B)IBA
08/2016
1Rosiglitazone (Avandia)FDA Link
08/2016
1Cyclin D1IBA
08/2016
1honokiolIBA
08/2016
1CyclinsIBA
08/2016
1ThiazolidinedionesIBA
08/2016
1LigandsIBA
07/2016
1Glucose (Dextrose)FDA LinkGeneric
07/2016
1Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA
07/2016
1Peroxisome Proliferator-Activated Receptors (PPAR)IBA
07/2016
1LipidsIBA
07/2016
1BiguanidesIBA
09/2015
1Tissue Inhibitor of Metalloproteinase-2IBA
07/2015
1Tissue Inhibitor of Metalloproteinase-1IBA
07/2015
1Sorafenib (BAY 43-9006)FDA Link
03/2015
1Messenger RNA (mRNA)IBA
10/2013
1Mitochondrial DNA (mtDNA)IBA
10/2013
1Transcription Factors (Transcription Factor)IBA
10/2013
1Adenosine Triphosphate (ATP)IBA
10/2013
1Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
11/2012
1Vitamin B 12 (Cyanocobalamin)FDA LinkGeneric
11/2012
1Methionine (L-Methionine)FDA Link
11/2012
1Betaine (C.B.B.)FDA Link
11/2012
1Pyridoxine (Pyridoxin)FDA LinkGeneric
11/2012
1Folic Acid (Vitamin M)FDA LinkGeneric
11/2012
1Amino AcidsFDA Link
02/2012

Therapy/Procedure

14Liver Transplantation
01/2022 - 11/2006
11Therapeutics
01/2022 - 01/2011
9Surgical Instruments (Clip)
04/2021 - 09/2007
4Radiofrequency Ablation
03/2016 - 01/2011
3Hepatectomy
07/2005 - 05/2003
2Transplantation
01/2022 - 02/2012
2Length of Stay
03/2012 - 05/2003
2Blood Transfusion (Blood Transfusions)
11/2003 - 05/2003
1Castration
12/2021
1Metastasectomy
01/2021
1Organ Transplantation
01/2020
1Lymph Node Excision (Lymph Node Dissection)
03/2017
1Drug Therapy (Chemotherapy)
04/2015